• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 3. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 4. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 5. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514

Recent Advances in the Study of 5-Amino-6-bromo-2,2-difluorobenzodioxole (CAS: 887267-84-7): A Promising Intermediate in Medicinal Chemistry

The compound 5-Amino-6-bromo-2,2-difluorobenzodioxole (CAS: 887267-84-7) has recently garnered significant attention in the field of medicinal chemistry due to its versatile applications as a key intermediate in the synthesis of biologically active molecules. This heterocyclic scaffold, characterized by its unique difluorobenzodioxole core, has been employed in the development of novel therapeutic agents targeting a range of diseases, including cancer, infectious diseases, and neurological disorders. Recent studies have highlighted its potential in facilitating the synthesis of potent kinase inhibitors, antimicrobial agents, and modulators of protein-protein interactions.

One of the most notable applications of 5-Amino-6-bromo-2,2-difluorobenzodioxole is its role in the synthesis of small-molecule inhibitors targeting protein kinases. Kinases play a critical role in cellular signaling pathways, and their dysregulation is implicated in numerous diseases, particularly cancer. Researchers have utilized this compound as a building block to develop selective kinase inhibitors with improved pharmacokinetic properties. For instance, a recent study published in the Journal of Medicinal Chemistry demonstrated the successful incorporation of this intermediate into a series of compounds exhibiting nanomolar potency against specific kinase targets, with enhanced selectivity and reduced off-target effects.

In addition to its applications in kinase inhibitor development, 5-Amino-6-bromo-2,2-difluorobenzodioxole has also been explored in the context of antimicrobial drug discovery. The difluorobenzodioxole moiety has been shown to confer favorable physicochemical properties, such as increased metabolic stability and improved membrane permeability, which are critical for antimicrobial efficacy. Recent research has reported the synthesis of novel antibacterial and antifungal agents incorporating this scaffold, with promising activity against drug-resistant strains. These findings underscore the potential of this compound in addressing the growing challenge of antimicrobial resistance.

Beyond its therapeutic applications, the synthetic utility of 5-Amino-6-bromo-2,2-difluorobenzodioxole has been further demonstrated in the development of fluorescent probes and imaging agents. The bromo and amino functional groups provide convenient handles for further chemical modifications, enabling the attachment of fluorophores or other reporter groups. This has facilitated the design of tools for studying biological processes at the molecular level, offering insights into disease mechanisms and drug-target interactions.

Despite these advancements, challenges remain in the large-scale synthesis and optimization of derivatives based on this scaffold. Recent efforts have focused on improving synthetic routes to enhance yield and purity, as well as exploring novel derivatization strategies to expand the chemical space accessible from this intermediate. Collaborative research between academic and industrial laboratories is expected to drive further innovation in this area, paving the way for the discovery of next-generation therapeutics.

In conclusion, 5-Amino-6-bromo-2,2-difluorobenzodioxole (CAS: 887267-84-7) represents a valuable intermediate in medicinal chemistry, with demonstrated applications in drug discovery and chemical biology. Its unique structural features and versatile reactivity make it a promising candidate for the development of novel therapeutic agents and research tools. Continued research into its synthetic applications and biological activities is likely to yield significant contributions to the field of chemical biology and pharmaceutical sciences.

• 1544-85-0(2,2-difluoro-2H-1,3-benzodioxol-5-amine)
• 1804848-55-2(2-Bromo-4-methoxy-5-(trifluoromethoxy)aniline)
• 1807214-56-7(2-Bromo-5-methoxy-4-(trifluoromethoxy)aniline)
• 1804896-10-3(2-Bromo-4-difluoromethoxy-5-(trifluoromethoxy)aniline)
• 1804847-41-3(2-Bromo-5-hydroxy-4-(trifluoromethoxy)aniline)
• 1806984-50-8(2-Bromo-4-hydroxy-5-(trifluoromethoxy)aniline)
• 1037763-48-6(5-Amino-4,6-dibromo-2,2-difluorobenzodioxole)
• 33070-32-5(5-bromo-2,2-difluoro-2H-1,3-benzodioxole)
• 56251-58-2(6-bromo-2H-1,3-benzodioxol-5-amine)
• 1807030-54-1(2-Bromo-5-difluoromethoxy-4-(trifluoromethoxy)aniline)